Fair value measurements (Tables)
|
12 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Fair value of financial assets and financial liabilities carried on recurring basis |
The following tables present the amounts of Nomura’s financial instruments carried at fair value on a recurring basis as of March 31, 2025 and 2026 within the fair value hierarchy.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
2,807 |
|
|
¥ |
1,661 |
|
|
¥ |
21 |
|
|
¥ |
— |
|
|
¥ |
4,489 |
|
Private equity and debt investments (5) |
|
|
0 |
|
|
|
2 |
|
|
|
103 |
|
|
|
— |
|
|
|
105 |
|
Japanese government securities |
|
|
2,674 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,674 |
|
Japanese agency and municipal securities |
|
|
— |
|
|
|
222 |
|
|
|
0 |
|
|
|
— |
|
|
|
222 |
|
Foreign government, agency and municipal securities |
|
|
4,402 |
|
|
|
2,346 |
|
|
|
6 |
|
|
|
— |
|
|
|
6,754 |
|
Bank and corporate debt securities and loans for trading purposes |
|
|
— |
|
|
|
1,762 |
|
|
|
181 |
|
|
|
— |
|
|
|
1,943 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
— |
|
|
|
2 |
|
|
|
10 |
|
|
|
— |
|
|
|
12 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
— |
|
|
|
3,335 |
|
|
|
48 |
|
|
|
— |
|
|
|
3,383 |
|
Issued/Guaranteed by government sponsored entity |
|
|
— |
|
|
|
3,204 |
|
|
|
— |
|
|
|
— |
|
|
|
3,204 |
|
|
|
|
— |
|
|
|
131 |
|
|
|
48 |
|
|
|
— |
|
|
|
179 |
|
Real estate-backed securities |
|
|
— |
|
|
|
137 |
|
|
|
207 |
|
|
|
— |
|
|
|
344 |
|
Collateralized debt obligations (“CDOs”) and other (6) |
|
|
— |
|
|
|
35 |
|
|
|
42 |
|
|
|
— |
|
|
|
77 |
|
Investment trust funds and other |
|
|
470 |
|
|
|
7 |
|
|
|
3 |
|
|
|
— |
|
|
|
480 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading assets and private equity and debt investments |
|
|
10,353 |
|
|
|
9,509 |
|
|
|
621 |
|
|
|
— |
|
|
|
20,483 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
2,541 |
|
|
|
17 |
|
|
|
— |
|
|
|
2,572 |
|
|
|
|
22 |
|
|
|
12,306 |
|
|
|
100 |
|
|
|
— |
|
|
|
12,428 |
|
|
|
|
1 |
|
|
|
240 |
|
|
|
63 |
|
|
|
— |
|
|
|
304 |
|
Foreign exchange contracts |
|
|
0 |
|
|
|
4,330 |
|
|
|
33 |
|
|
|
— |
|
|
|
4,363 |
|
|
|
|
3 |
|
|
|
5 |
|
|
|
3 |
|
|
|
— |
|
|
|
11 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(17,711 |
) |
|
|
(17,711 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
40 |
|
|
|
19,422 |
|
|
|
216 |
|
|
|
(17,711 |
) |
|
|
1,967 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
10,393 |
|
|
¥ |
28,931 |
|
|
¥ |
837 |
|
|
¥ |
(17,711 |
) |
|
¥ |
22,450 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
— |
|
|
|
1,795 |
|
|
|
448 |
|
|
|
— |
|
|
|
2,243 |
|
Collateralized agreements (9) |
|
|
— |
|
|
|
344 |
|
|
|
15 |
|
|
|
— |
|
|
|
359 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities (10) |
|
|
116 |
|
|
|
352 |
|
|
|
17 |
|
|
|
— |
|
|
|
485 |
|
|
|
|
211 |
|
|
|
259 |
|
|
|
275 |
|
|
|
— |
|
|
|
745 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
10,720 |
|
|
¥ |
31,681 |
|
|
¥ |
1,592 |
|
|
¥ |
(17,711 |
) |
|
¥ |
26,282 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
2,757 |
|
|
¥ |
18 |
|
|
¥ |
1 |
|
|
¥ |
— |
|
|
¥ |
2,776 |
|
Japanese government securities |
|
|
2,569 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,569 |
|
Japanese agency and municipal securities |
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Foreign government, agency and municipal securities |
|
|
2,828 |
|
|
|
754 |
|
|
|
— |
|
|
|
— |
|
|
|
3,582 |
|
Bank and corporate debt securities |
|
|
— |
|
|
|
217 |
|
|
|
0 |
|
|
|
— |
|
|
|
217 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
Collateralized Debt Obligation (CDO) and Other Securitized Product (6) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Investment trust funds and other |
|
|
249 |
|
|
|
2 |
|
|
|
0 |
|
|
|
— |
|
|
|
251 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading liabilities |
|
|
8,403 |
|
|
|
993 |
|
|
|
1 |
|
|
|
— |
|
|
|
9,397 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
3,048 |
|
|
|
16 |
|
|
|
— |
|
|
|
3,069 |
|
|
|
|
31 |
|
|
|
11,523 |
|
|
|
94 |
|
|
|
— |
|
|
|
11,648 |
|
|
|
|
1 |
|
|
|
282 |
|
|
|
99 |
|
|
|
— |
|
|
|
382 |
|
Foreign exchange contracts |
|
|
— |
|
|
|
4,148 |
|
|
|
46 |
|
|
|
— |
|
|
|
4,194 |
|
|
|
|
1 |
|
|
|
42 |
|
|
|
7 |
|
|
|
— |
|
|
|
50 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(17,361 |
) |
|
|
(17,361 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivative liabilities |
|
|
38 |
|
|
|
19,043 |
|
|
|
262 |
|
|
|
(17,361 |
) |
|
|
1,982 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
8,441 |
|
|
¥ |
20,036 |
|
|
¥ |
263 |
|
|
¥ |
(17,361 |
) |
|
¥ |
11,379 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings (12) |
|
¥ |
— |
|
|
¥ |
595 |
|
|
¥ |
36 |
|
|
¥ |
— |
|
|
¥ |
631 |
|
Payables and deposits (13)(14) |
|
|
— |
|
|
|
311 |
|
|
|
14 |
|
|
|
— |
|
|
|
325 |
|
Collateralized financing (9) |
|
|
— |
|
|
|
704 |
|
|
|
— |
|
|
|
— |
|
|
|
704 |
|
Long-term borrowings (12)(15)(16) |
|
|
10 |
|
|
|
6,428 |
|
|
|
477 |
|
|
|
— |
|
|
|
6,915 |
|
|
|
|
132 |
|
|
|
265 |
|
|
|
65 |
|
|
|
— |
|
|
|
462 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
8,583 |
|
|
¥ |
28,339 |
|
|
¥ |
855 |
|
|
¥ |
(17,361 |
) |
|
¥ |
20,416 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash Collateral Netting (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
3,992 |
|
|
¥ |
1,576 |
|
|
¥ |
14 |
|
|
¥ |
— |
|
|
¥ |
5,582 |
|
Private equity and debt investments (5) |
|
|
— |
|
|
|
2 |
|
|
|
146 |
|
|
|
— |
|
|
|
148 |
|
Japanese government securities |
|
|
3,983 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
3,983 |
|
Japanese agency and municipal securities |
|
|
— |
|
|
|
142 |
|
|
|
— |
|
|
|
— |
|
|
|
142 |
|
Foreign government, agency and municipal securities |
|
|
4,591 |
|
|
|
2,549 |
|
|
|
4 |
|
|
|
— |
|
|
|
7,144 |
|
Bank and corporate debt securities and loans for trading purposes |
|
|
— |
|
|
|
2,028 |
|
|
|
104 |
|
|
|
— |
|
|
|
2,132 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
— |
|
|
|
9 |
|
|
|
0 |
|
|
|
— |
|
|
|
9 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
— |
|
|
|
3,172 |
|
|
|
10 |
|
|
|
— |
|
|
|
3,182 |
|
Issued/Guaranteed by government sponsored entity |
|
|
— |
|
|
|
3,021 |
|
|
|
— |
|
|
|
— |
|
|
|
3,021 |
|
|
|
|
— |
|
|
|
151 |
|
|
|
10 |
|
|
|
— |
|
|
|
161 |
|
Real estate-backed securities |
|
|
— |
|
|
|
445 |
|
|
|
82 |
|
|
|
— |
|
|
|
527 |
|
Collateralized debt obligations (“CDOs”) and other (6) |
|
|
— |
|
|
|
25 |
|
|
|
34 |
|
|
|
— |
|
|
|
59 |
|
Investment trust funds and other |
|
|
372 |
|
|
|
56 |
|
|
|
9 |
|
|
|
— |
|
|
|
437 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading assets and private equity and debt investments |
|
|
12,938 |
|
|
|
10,004 |
|
|
|
403 |
|
|
|
— |
|
|
|
23,345 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
3,016 |
|
|
|
37 |
|
|
|
— |
|
|
|
3,053 |
|
|
|
|
1 |
|
|
|
15,686 |
|
|
|
119 |
|
|
|
— |
|
|
|
15,806 |
|
|
|
|
0 |
|
|
|
296 |
|
|
|
98 |
|
|
|
— |
|
|
|
394 |
|
Foreign exchange contracts |
|
|
0 |
|
|
|
5,709 |
|
|
|
35 |
|
|
|
— |
|
|
|
5,744 |
|
|
|
|
0 |
|
|
|
3 |
|
|
|
6 |
|
|
|
— |
|
|
|
9 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(22,113 |
) |
|
|
(22,113 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
24,710 |
|
|
|
295 |
|
|
|
(22,113 |
) |
|
|
2,893 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
12,939 |
|
|
¥ |
34,714 |
|
|
¥ |
698 |
|
|
¥ |
(22,113 |
) |
|
¥ |
26,238 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
2,244 |
|
|
|
584 |
|
|
|
— |
|
|
|
2,834 |
|
Collateralized agreements (9) |
|
|
— |
|
|
|
455 |
|
|
|
16 |
|
|
|
— |
|
|
|
471 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities (10) |
|
|
347 |
|
|
|
366 |
|
|
|
48 |
|
|
|
— |
|
|
|
761 |
|
|
|
|
368 |
|
|
|
264 |
|
|
|
308 |
|
|
|
— |
|
|
|
940 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
13,660 |
|
|
¥ |
38,043 |
|
|
¥ |
1,654 |
|
|
¥ |
(22,113 |
) |
|
¥ |
31,244 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
3,438 |
|
|
¥ |
34 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
3,472 |
|
Japanese government securities |
|
|
2,719 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2,719 |
|
Japanese agency and municipal securities |
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
Foreign government, agency and municipal securities |
|
|
2,694 |
|
|
|
1,255 |
|
|
|
— |
|
|
|
— |
|
|
|
3,949 |
|
Bank and corporate debt securities |
|
|
— |
|
|
|
220 |
|
|
|
0 |
|
|
|
— |
|
|
|
220 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
Collateralized Debt Obligation (CDO) and Other Securitized Product (6) |
|
|
— |
|
|
|
0 |
|
|
|
1 |
|
|
|
— |
|
|
|
1 |
|
Investment trust funds and other |
|
|
120 |
|
|
|
13 |
|
|
|
— |
|
|
|
— |
|
|
|
133 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading liabilities |
|
|
8,971 |
|
|
|
1,524 |
|
|
|
1 |
|
|
|
— |
|
|
|
10,496 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative liabilities (7) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
0 |
|
|
|
3,561 |
|
|
|
10 |
|
|
|
— |
|
|
|
3,571 |
|
|
|
|
24 |
|
|
|
14,476 |
|
|
|
135 |
|
|
|
— |
|
|
|
14,635 |
|
|
|
|
3 |
|
|
|
402 |
|
|
|
154 |
|
|
|
— |
|
|
|
559 |
|
Foreign exchange contracts |
|
|
— |
|
|
|
5,292 |
|
|
|
57 |
|
|
|
— |
|
|
|
5,349 |
|
|
|
|
2 |
|
|
|
27 |
|
|
|
8 |
|
|
|
— |
|
|
|
37 |
|
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(21,731 |
) |
|
|
(21,731 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivative liabilities |
|
|
29 |
|
|
|
23,758 |
|
|
|
364 |
|
|
|
(21,731 |
) |
|
|
2,420 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
9,000 |
|
|
¥ |
25,282 |
|
|
¥ |
365 |
|
|
¥ |
(21,731 |
) |
|
¥ |
12,916 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings (12) |
|
¥ |
— |
|
|
¥ |
873 |
|
|
¥ |
43 |
|
|
¥ |
— |
|
|
¥ |
916 |
|
Payables and deposits (13)(14) |
|
|
— |
|
|
|
303 |
|
|
|
12 |
|
|
|
— |
|
|
|
315 |
|
Collateralized financing (9) |
|
|
— |
|
|
|
694 |
|
|
|
— |
|
|
|
— |
|
|
|
694 |
|
Long-term borrowings (12)(15)(16) |
|
|
11 |
|
|
|
8,024 |
|
|
|
452 |
|
|
|
— |
|
|
|
8,487 |
|
|
|
|
255 |
|
|
|
284 |
|
|
|
67 |
|
|
|
— |
|
|
|
606 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
9,266 |
|
|
¥ |
35,460 |
|
|
¥ |
939 |
|
|
¥ |
(21,731 |
) |
|
¥ |
23,934 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents the amount offset under counterparty netting of derivative assets and liabilities as well as cash collateral netting against net derivatives assets or liabilities. |
| (2) |
Investments that are carried at fair value using NAV per share as a practical expedient have not been classified in the fair value hierarchy. As of March 31, 2025 and March 31, 2026, the fair values of these investments which are included in Trading assets and private equity and debt investments were ¥73 billion and ¥104 billion, respectively. As of March 31, 2025 and March 31, 2026, the fair values of these investments which are included in were ¥3 billion and ¥15 billion, respectively. |
| (3) |
Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the FVO. |
| (4) |
Includes equity investments which comprise listed and unlisted equity securities held for operating purposes in the amounts of ¥72,184 million and ¥26,217 million, respectively, as of March 31, 2025 and ¥97,173 million and ¥26,018 million, respectively, as of March 31, 2026. |
| (5) |
Private equity and debt investments include minority private equity and venture capital equity investments and other junior debt investments such as mezzanine debt held for non-trading purposes, and post-IPO investments. These investments also include equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the FVO. |
| (6) |
Includes collateralized loan obligations (“CLOs”) and asset-backed securities (“ABS”) such as those secured on credit card loans, auto loans and student loans. |
| (7) |
Derivatives which contain multiple types of risk are classified based on the primary risk type of the instrument. |
| (8) |
Includes loans and receivables for which the fair value option has been elected. |
| (9) |
Includes collateralized agreements or collateralized financing for which the FVO has been elected. |
| (10) |
Includes non-trading debt securities for which the FVO has been elected and AFS debt securities. |
| (11) |
Includes non-financial assets carried at fair value on a recurring basis using similar valuation methodologies to those used for financial instruments. |
| (12) |
Includes structured notes for which the FVO has been elected. |
| (13) |
Includes deposits received at banks for which the FVO has been elected. |
| (14) |
Includes embedded derivatives bifurcated from deposits received at banks. Deposits are adjusted for fair value changes in corresponding embedded derivatives for presentation in the consolidated balance sheets. |
| (15) |
Includes embedded derivatives bifurcated from issued structured notes. Structured notes are adjusted for fair value changes in corresponding embedded derivatives for presentation in the consolidated balance sheets |
| (16) |
Includes liabilities recognized from secured financing transactions that are accounted for as financings rather than sales. Nomura elected the fair value option for these liabilities. |
| (17) |
Includes loan commitments for which the FVO has been elected. |
|
| Schedule of quantitative and qualitative information regarding significant unobservable inputs and assumptions for certain level 3 financial instruments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
| |
|
Fair value in billions of yen |
|
|
|
|
unobservable valuation input |
|
|
|
|
|
Impact of increases in significant unobservable valuation |
|
Interrelationships between valuation |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
¥ |
21 |
|
|
DCF/ Option models |
|
Credit spreads |
|
2.5% |
|
2.5% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private equity and debt investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market multiples |
|
EV/EBITDA ratios |
|
7.8 – 16.2 x |
|
10.0 x |
|
Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
PE Ratios |
|
10.6 – 28.4 x |
|
15.2 x |
|
Higher fair value |
|
|
|
|
|
|
|
|
Liquidity discounts |
|
5.0 – 20.0% |
|
9.6% |
|
Lower fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign government, agency and municipal securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank and corporate debt securities and loans for trading purposes |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
Fair value in billions of yen |
|
|
|
|
unobservable valuation input |
|
|
|
|
|
Impact of increases in significant unobservable valuation |
|
Interrelationships between valuation |
Commercial mortgage- backed securities (“CMBS”) |
|
¥ |
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Residential mortgage-backed securities (“RMBS”) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate-backed securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized debt obligations (“CDOs”) and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in default probabilities typically accompanied by directionally similar change in loss severities and opposite change in prepayment rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment trust funds and other |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity contracts |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(36) |
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange contracts |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized agreements |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Financial Instrument |
|
Fair value in billions of yen |
|
|
Valuation technique |
|
Significant unobservable valuation input |
|
Range of valuation |
|
Weighted |
|
Impact of increases in significant unobservable valuation |
|
Interrelationships between valuation |
|
|
¥ |
275 |
|
|
DCF |
|
WACC Growth rates |
|
10.6% 3.0% |
|
10.6% 3.0% |
|
Lower fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market multiples |
|
Liquidity discounts |
|
25.0% |
|
25.0% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings |
|
|
36 |
|
|
DCF/ Option models |
|
Volatilities Correlations |
|
5.0 – 51.5% (0.72) – 0.96 |
|
— — |
|
Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Payable and deposits |
|
|
14 |
|
|
DCF/ Option models |
|
Volatilities Correlations |
|
9.8 – 10.6% 0.40 – 0.98 |
|
— — |
|
Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term borrowings |
|
|
477 |
|
|
DCF |
|
Loss severities |
|
12.7 – 99.5% |
|
79.8% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DCF/ Option models |
|
Volatilities Volatilities Correlations |
|
5.0 – 51.5% 44.1 – 67.9 bp (1.00) – 0.99 |
|
— — — |
|
Higher fair value Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other liabilities |
|
|
65 |
|
|
DCF |
|
Credit spreads Recovery rates |
|
0.8 – 7.1% 91.0 – 99.5% |
|
1.0% 93.8% |
|
Lower fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Financial Instrument |
|
Fair value in billions of yen |
|
|
Valuation technique |
|
Significant unobservable valuation input |
|
Range of valuation |
|
Weighted |
|
Impact of increases in significant unobservable valuation |
|
Interrelationships between valuation |
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities |
|
¥ |
14 |
|
|
DCF/ Option models |
|
Credit spreads |
|
2.9% |
|
2.9% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Private equity and debt investments |
|
|
146 |
|
|
DCF |
|
WACC Growth rates Credit spreads Liquidity discounts |
|
7.5 – 16.2% 0.0 – 2.0% 0.0 – 49.9% 0.0 – 30.0% |
|
12.2% 1.7% 8.5% 11.0% |
|
Lower fair value Higher fair value Lower fair value Lower fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market multiples |
|
EV/EBITDA ratios |
|
5.9 – 11.4 x |
|
8.9 x |
|
Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
PE Ratios |
|
12.1 – 20.8 x |
|
15.2 x |
|
Higher fair value |
|
|
|
|
|
|
|
|
Liquidity discounts |
|
10.0 – 20.0% |
|
12.6% |
|
Lower fair value |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign government, agency and municipal securities |
|
|
4 |
|
|
DCF |
|
Credit spreads Recovery rates |
|
0.0 – 2.3% 12.5 – 18.0% |
|
1.1% 17.2% |
|
Lower fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Bank and corporate debt securities and loans for trading purposes |
|
|
104 |
|
|
DCF |
|
Credit spreads Recovery rates |
|
0.5 – 12.6% 0.0 – 99.5% |
|
4.8% 38.2% |
|
Lower fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
Financial Instrument |
|
Fair value in billions of yen |
|
|
Valuation technique |
|
Significant unobservable valuation input |
|
Range of valuation |
|
Weighted |
|
Impact of increases in significant unobservable valuation |
|
Interrelationships between valuation |
Residential mortgage-backed securities (“RMBS”) |
|
¥ |
10 |
|
|
DCF |
|
Yields Prepayment rates Loss severities |
|
140.2% 12.0% 0.0 – 100.0% |
|
140.2% 12.0% 9.4% |
|
Lower fair value Lower fair value Lower fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Real estate-backed securities |
|
|
82 |
|
|
DCF |
|
Loss severities |
|
0.0 – 17.5% |
|
0.5% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized debt obligations (“CDOs”) and other |
|
|
34 |
|
|
DCF |
|
Yields Prepayment rates Default probabilities Loss severities Credit spreads |
|
8.5 – 40.7% 20.0% 2.0% 69.3 – 100.0% 0.2% |
|
17.9% 20.0% 2.0% 93.6% 0.2% |
|
Lower fair value Lower fair value Lower fair value Lower fair value Lower fair value |
|
Change in default probabilities typically accompanied by directionally similar change in loss severities and opposite change in prepayment rates |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Investment trust funds and other |
|
|
9 |
|
|
DCF |
|
Liquidity discounts |
|
2.4 – 15.2% |
|
5.5% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivatives, net: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity contracts |
|
|
27 |
|
|
Option models |
|
Dividend yield Volatilities Correlations |
|
0.0 – 12.6% 3.7 – 100.9% (0.85) – 0.98 |
|
— — — |
|
Higher fair value Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate contracts |
|
|
(16) |
|
|
DCF/ Option models |
|
Interest rates Volatilities Volatilities Correlations |
|
2.6 – 5.0% 9.7 – 13.0% 42.4 – 109.9 bp (1.00) – 1.00 |
|
— — — — |
|
Higher fair value Higher fair value Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit contracts |
|
|
(56) |
|
|
DCF/ Option models |
|
Credit spreads Recovery rates Volatilities Correlations |
|
0.0 – 156.3% 1.0 – 90.0% 25.0 – 81.6% 0.30 – 0.85 |
|
— — — — |
|
Higher fair value Higher fair value Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign exchange contracts |
|
|
(22) |
|
|
Option models |
|
Interest rates Volatilities Correlations |
|
3.1 – 3.1% 1.4 – 16.1% 0.24 – 0.70 |
|
— — — |
|
Higher fair value Higher fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and receivables |
|
|
584 |
|
|
DCF |
|
Credit spreads Recovery rates |
|
0.0 – 20.0% 64.5 – 100.0% |
|
5.9% 97.4% |
|
Lower fair value Higher fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Collateralized agreements |
|
|
16 |
|
|
DCF |
|
Repo rate |
|
5.2 – 5.6% |
|
5.4% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities |
|
|
48 |
|
|
DCF |
|
Credit spreads |
|
4.1 – 18.5% |
|
8.5% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
308 |
|
|
DCF |
|
WACC Growth rates Credit spreads |
|
10.5% 3.0% 0.3 – 22.0% |
|
10.5% 3.0% 3.2% |
|
Lower fair value Higher fair value Lower fair value |
|
No predictable interrelationship |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Market multiples |
|
Liquidity discounts |
|
25.0% |
|
25.0% |
|
Lower fair value |
|
Not applicable |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value in billions of yen |
|
|
|
|
unobservable valuation input |
|
|
|
|
|
Impact of increases in significant unobservable valuation |
|
Interrelationships between valuation |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DCF/ Option models |
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
DCF/ Option models |
|
Volatilities |
|
9.7 – 60.2% |
|
— |
|
Higher fair value |
|
No predictable interrelationship |
| |
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
DCF |
|
|
|
|
|
|
|
|
|
No predictable interrelationship |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Range information is provided in percentages, coefficients and multiples and represents the highest and lowest level significant unobservable valuation input used to value that type of financial instrument. A wide dispersion in the range does not necessarily reflect increased uncertainty or subjectivity in the valuation input and is typically just a consequence of the different characteristics of the financial instruments themselves. |
| (2) |
Weighted average information for non-derivatives is calculated by weighting each valuation input by the fair value of the financial instrument. |
| (3) |
Nomura has not provided weighted average information for derivatives as unlike cash products the risk on such products is distinct from the balance sheet value and is subject to netting. Discussion of the ranges of significant unobservable valuation inputs for derivatives and short-term and long-term borrowings which contain embedded derivatives classified in Level 3 is provided below as a substitute for weighted average information. |
| (4) |
The above table only considers the impact of an increase in each significant unobservable valuation input on the fair value measurement of the financial instrument. However, a decrease in the significant unobservable valuation input would have the opposite effect on the fair value measurement of the financial instrument. For example, if an increase in a significant unobservable valuation input would result in a lower fair value measurement, a decrease in the significant unobservable valuation input would result in a higher fair value measurement. |
| (5) |
The impact of an increase in the significant unobservable valuation input on the fair value measurement for a derivative assumes Nomura is long risk to the input (such as being long volatility). Where Nomura is short such risk, the impact of an increase would have a converse effect on the fair value measurement of the derivative. |
| (6) |
Consideration of the interrelationships between significant unobservable valuation inputs is only relevant where more than one unobservable valuation input is used to determine the fair value measurement of the financial instrument. |
| (7) |
Valuation techniques and unobservable valuation inputs in respect of equity securities reported within in the consolidated balance sheets. |
| (8) |
Includes non-financial assets carried at fair value on a recurring basis |
|
| Increases and decreases of Level 3 assets and liabilities measured at fair value on recurring basis unrealized and realized gain/losses included in revenue |
For the years ended March 31, 2025 and 2026, gains and losses related to Level 3 assets and liabilities did not have a material impact on Nomura’s liquidity and capital resources management.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended March 31, 2025 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
8 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
17 |
|
|
¥ |
(13 |
) |
|
¥ |
— |
|
|
¥ |
1 |
|
|
¥ |
15 |
|
|
¥ |
(7 |
) |
|
¥ |
21 |
|
Private equity and debt investments |
|
|
80 |
|
|
|
3 |
|
|
|
— |
|
|
|
37 |
|
|
|
(9 |
) |
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
(8 |
) |
|
|
103 |
|
Japanese agency and municipal securities |
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
Foreign government, agency and municipal securities |
|
|
3 |
|
|
|
0 |
|
|
|
— |
|
|
|
5 |
|
|
|
(5 |
) |
|
|
— |
|
|
|
0 |
|
|
|
7 |
|
|
|
(4 |
) |
|
|
6 |
|
Bank and corporate debt securities and loans for trading purposes |
|
|
173 |
|
|
|
(5 |
) |
|
|
— |
|
|
|
205 |
|
|
|
(240 |
) |
|
|
— |
|
|
|
(5 |
) |
|
|
69 |
|
|
|
(16 |
) |
|
|
181 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
0 |
|
|
|
2 |
|
|
|
— |
|
|
|
7 |
|
|
|
(6 |
) |
|
|
— |
|
|
|
— |
|
|
|
7 |
|
|
|
— |
|
|
|
10 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
35 |
|
|
|
2 |
|
|
|
— |
|
|
|
56 |
|
|
|
(46 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
2 |
|
|
|
0 |
|
|
|
48 |
|
Real estate-backed securities |
|
|
122 |
|
|
|
11 |
|
|
|
— |
|
|
|
370 |
|
|
|
(294 |
) |
|
|
— |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
207 |
|
Collateralized debt obligations (“CDOs”) and other |
|
|
46 |
|
|
|
(25 |
) |
|
|
— |
|
|
|
107 |
|
|
|
(86 |
) |
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
42 |
|
Investment trust funds and other |
|
|
3 |
|
|
|
0 |
|
|
|
— |
|
|
|
68 |
|
|
|
(68 |
) |
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
3 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading assets and private equity and debt investments |
|
|
470 |
|
|
|
(12 |
) |
|
|
— |
|
|
|
872 |
|
|
|
(767 |
) |
|
|
— |
|
|
|
(7 |
) |
|
|
100 |
|
|
|
(35 |
) |
|
|
621 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5 |
) |
|
|
0 |
|
|
|
0 |
|
|
|
1 |
|
|
|
1 |
|
|
|
|
32 |
|
|
|
(20 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
12 |
|
|
|
(4 |
) |
|
|
(19 |
) |
|
|
5 |
|
|
|
6 |
|
|
|
|
(46 |
) |
|
|
(30 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
37 |
|
|
|
1 |
|
|
|
(1 |
) |
|
|
3 |
|
|
|
(36 |
) |
Foreign exchange contracts |
|
|
3 |
|
|
|
(9 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(5 |
) |
|
|
0 |
|
|
|
0 |
|
|
|
(2 |
) |
|
|
(13 |
) |
|
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
(2 |
) |
|
|
(5 |
) |
|
|
— |
|
|
|
(4 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(6 |
) |
|
|
(57 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
40 |
|
|
|
(5 |
) |
|
|
(25 |
) |
|
|
7 |
|
|
|
(46 |
) |
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
464 |
|
|
¥ |
(69 |
) |
|
¥ |
— |
|
|
¥ |
872 |
|
|
¥ |
(767 |
) |
|
¥ |
40 |
|
|
¥ |
(12 |
) |
|
¥ |
75 |
|
|
¥ |
(28 |
) |
|
¥ |
575 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
291 |
|
|
¥ |
24 |
|
|
¥ |
— |
|
|
¥ |
199 |
|
|
¥ |
(234 |
) |
|
¥ |
— |
|
|
¥ |
(14 |
) |
|
¥ |
244 |
|
|
¥ |
(62 |
) |
|
¥ |
448 |
|
Collateralized agreements |
|
|
12 |
|
|
|
0 |
|
|
|
— |
|
|
|
2 |
|
|
|
— |
|
|
|
1 |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities |
|
|
21 |
|
|
|
0 |
|
|
|
— |
|
|
|
3 |
|
|
|
(7 |
) |
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
17 |
|
|
|
|
253 |
|
|
|
20 |
|
|
|
— |
|
|
|
45 |
|
|
|
(11 |
) |
|
|
— |
|
|
|
(4 |
) |
|
|
0 |
|
|
|
(28 |
) |
|
|
275 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
1,041 |
|
|
¥ |
(25 |
) |
|
¥ |
— |
|
|
¥ |
1,121 |
|
|
¥ |
(1,019 |
) |
|
¥ |
41 |
|
|
¥ |
(30 |
) |
|
¥ |
319 |
|
|
¥ |
(118 |
) |
|
¥ |
1,330 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
3 |
|
|
¥ |
(2 |
) |
|
¥ |
— |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
1 |
|
Bank and corporate debt securities |
|
|
1 |
|
|
|
0 |
|
|
|
— |
|
|
|
2 |
|
|
|
(3 |
) |
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
Collateralized debt obligations (“CDOs”) and other |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
Investment trust funds and other |
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading liabilities |
|
¥ |
1 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
5 |
|
|
¥ |
(5 |
) |
|
¥ |
— |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
1 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23 |
|
|
|
(1 |
) |
|
|
0 |
|
|
|
70 |
|
|
|
(41 |
) |
|
|
— |
|
|
|
0 |
|
|
|
1 |
|
|
|
(18 |
) |
|
|
36 |
|
|
|
|
15 |
|
|
|
1 |
|
|
|
0 |
|
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
(2 |
) |
|
|
14 |
|
|
|
|
474 |
|
|
|
0 |
|
|
|
9 |
|
|
|
218 |
|
|
|
(172 |
) |
|
|
— |
|
|
|
0 |
|
|
|
11 |
|
|
|
(45 |
) |
|
|
477 |
|
|
|
|
44 |
|
|
|
0 |
|
|
|
— |
|
|
|
47 |
|
|
|
(25 |
) |
|
|
— |
|
|
|
(1 |
) |
|
|
0 |
|
|
|
0 |
|
|
|
65 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
557 |
|
|
¥ |
0 |
|
|
¥ |
9 |
|
|
¥ |
341 |
|
|
¥ |
(243 |
) |
|
¥ |
— |
|
|
¥ |
(1 |
) |
|
¥ |
13 |
|
|
¥ |
(65) |
|
|
¥ |
593 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
Year ended March 31, 2026 |
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities |
|
¥ |
21 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
16 |
|
|
¥ |
(36 |
) |
|
¥ |
— |
|
|
¥ |
2 |
|
|
¥ |
14 |
|
|
¥ |
(3 |
) |
|
¥ |
14 |
|
Private equity and debt investments |
|
|
103 |
|
|
|
5 |
|
|
|
— |
|
|
|
101 |
|
|
|
(44 |
) |
|
|
— |
|
|
|
1 |
|
|
|
1 |
|
|
|
(21 |
) |
|
|
146 |
|
Japanese agency and municipal securities |
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
Foreign government, agency and municipal securities |
|
|
6 |
|
|
|
1 |
|
|
|
— |
|
|
|
5 |
|
|
|
(6 |
) |
|
|
— |
|
|
|
0 |
|
|
|
4 |
|
|
|
(6 |
) |
|
|
4 |
|
Bank and corporate debt securities and loans for trading purposes |
|
|
181 |
|
|
|
8 |
|
|
|
— |
|
|
|
103 |
|
|
|
(182 |
) |
|
|
— |
|
|
|
13 |
|
|
|
39 |
|
|
|
(58 |
) |
|
|
104 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
10 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
(10 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
48 |
|
|
|
(3 |
) |
|
|
— |
|
|
|
3 |
|
|
|
(20 |
) |
|
|
— |
|
|
|
2 |
|
|
|
1 |
|
|
|
(21 |
) |
|
|
10 |
|
Real estate-backed securities |
|
|
207 |
|
|
|
0 |
|
|
|
— |
|
|
|
362 |
|
|
|
(287 |
) |
|
|
— |
|
|
|
8 |
|
|
|
18 |
|
|
|
(226 |
) |
|
|
82 |
|
Collateralized debt obligations (“CDOs”) and other |
|
|
42 |
|
|
|
(9 |
) |
|
|
— |
|
|
|
39 |
|
|
|
(36 |
) |
|
|
— |
|
|
|
1 |
|
|
|
0 |
|
|
|
(3 |
) |
|
|
34 |
|
Investment trust funds and other |
|
|
3 |
|
|
|
0 |
|
|
|
— |
|
|
|
88 |
|
|
|
(79 |
) |
|
|
— |
|
|
|
0 |
|
|
|
5 |
|
|
|
(8 |
) |
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading assets and private equity and debt investments |
|
|
621 |
|
|
|
2 |
|
|
|
— |
|
|
|
719 |
|
|
|
(702 |
) |
|
|
— |
|
|
|
27 |
|
|
|
82 |
|
|
|
(346 |
) |
|
|
403 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity contracts |
|
|
1 |
|
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
32 |
|
|
|
(1 |
) |
|
|
(15 |
) |
|
|
8 |
|
|
|
27 |
|
Interest rate contracts |
|
|
6 |
|
|
|
16 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(29 |
) |
|
|
2 |
|
|
|
8 |
|
|
|
(19 |
) |
|
|
(16 |
) |
Credit contracts |
|
|
(36 |
) |
|
|
2 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(25 |
) |
|
|
(2 |
) |
|
|
12 |
|
|
|
(7 |
) |
|
|
(56 |
) |
Foreign exchange contracts |
|
|
(13 |
) |
|
|
(12 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
4 |
|
|
|
1 |
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(22 |
) |
Other contracts |
|
|
(4 |
) |
|
|
(2 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
2 |
|
|
|
0 |
|
|
|
2 |
|
|
|
— |
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total derivatives, net |
|
|
(46 |
) |
|
|
6 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
(16 |
) |
|
|
0 |
|
|
|
6 |
|
|
|
(19 |
) |
|
|
(69 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Subtotal |
|
¥ |
575 |
|
|
¥ |
8 |
|
|
¥ |
— |
|
|
¥ |
719 |
|
|
¥ |
(702 |
) |
|
¥ |
(16 |
) |
|
¥ |
27 |
|
|
¥ |
88 |
|
|
¥ |
(365 |
) |
|
¥ |
334 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loans and receivables |
|
¥ |
448 |
|
|
¥ |
32 |
|
|
¥ |
— |
|
|
¥ |
237 |
|
|
¥ |
(285 |
) |
|
¥ |
— |
|
|
¥ |
40 |
|
|
¥ |
178 |
|
|
¥ |
(66 |
) |
|
¥ |
584 |
|
Collateralized agreements |
|
|
15 |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
|
|
— |
|
|
|
— |
|
|
|
16 |
|
Other assets |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-trading debt securities |
|
|
17 |
|
|
|
2 |
|
|
|
— |
|
|
|
10 |
|
|
|
(8 |
) |
|
|
— |
|
|
|
1 |
|
|
|
26 |
|
|
|
— |
|
|
|
48 |
|
|
|
|
275 |
|
|
|
32 |
|
|
|
— |
|
|
|
80 |
|
|
|
(99 |
) |
|
|
— |
|
|
|
21 |
|
|
|
1 |
|
|
|
(2 |
) |
|
|
308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
¥ |
1,330 |
|
|
¥ |
74 |
|
|
¥ |
— |
|
|
¥ |
1,046 |
|
|
¥ |
(1,094 |
) |
|
¥ |
(16 |
) |
|
¥ |
90 |
|
|
¥ |
293 |
|
|
¥ |
(433 |
) |
|
¥ |
1,290 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Liabilities: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equities |
|
¥ |
1 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
— |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
(1 |
) |
|
¥ |
0 |
|
Bank and corporate debt securities |
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
|
|
0 |
|
Collateralized debt obligations (“CDOs”) and other |
|
|
0 |
|
|
|
(1 |
) |
|
|
— |
|
|
|
1 |
|
|
|
(1 |
) |
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
1 |
|
Investment trust funds and other |
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
0 |
|
|
|
— |
|
|
|
0 |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total trading liabilities |
|
¥ |
1 |
|
|
¥ |
(1 |
) |
|
¥ |
— |
|
|
¥ |
1 |
|
|
¥ |
(1 |
) |
|
¥ |
— |
|
|
¥ |
0 |
|
|
¥ |
0 |
|
|
¥ |
(1 |
) |
|
¥ |
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings |
|
|
36 |
|
|
|
(2 |
) |
|
|
0 |
|
|
|
96 |
|
|
|
(79 |
) |
|
|
— |
|
|
|
2 |
|
|
|
1 |
|
|
|
(15 |
) |
|
|
43 |
|
Payables and deposits |
|
|
14 |
|
|
|
1 |
|
|
|
0 |
|
|
|
— |
|
|
|
(1 |
) |
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
— |
|
|
|
12 |
|
Long-term borrowings |
|
|
477 |
|
|
|
(16 |
) |
|
|
(3 |
) |
|
|
194 |
|
|
|
(178 |
) |
|
|
— |
|
|
|
1 |
|
|
|
21 |
|
|
|
(82 |
) |
|
|
452 |
|
Other liabilities |
|
|
65 |
|
|
|
(1 |
) |
|
|
— |
|
|
|
100 |
|
|
|
(104 |
) |
|
|
— |
|
|
|
5 |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
67 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
¥ |
593 |
|
|
¥ |
(19 |
) |
|
¥ |
(3 |
) |
|
¥ |
391 |
|
|
¥ |
(363 |
) |
|
¥ |
— |
|
|
¥ |
8 |
|
|
¥ |
24 |
|
|
¥ |
(100) |
|
|
¥ |
575 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Includes gains and losses reported primarily within Net gain on trading, Gain on private equity and debt investments, and also within Gain (loss) on investments in equity securities, Revenue and Other, Interest and dividends and in the consolidated statements of income. |
| (2) |
Amounts reported in include increases in trading liabilities while include decreases in trading liabilities. |
| (3) |
Derivatives which contain multiple types of risk are classified based on the primary risk type of the instrument. |
| (4) |
Amounts of gains and losses on these transfers which were recognized in the period when the occurred were not significant for the years ended March 31, 2025 and March 31, 2026. |
| (5) |
indicate certain valuation inputs of a financial instrument become unobservable or significant. indicate certain valuation inputs of a financial instrument become observable or insignificant. See “ Quantitative and qualitative information regarding significant unobservable valuation inputs” above for the valuation inputs of each financial instruments. |
| (6) |
include financial instruments that moved out of level 3 by application of measurement alternative. See Note 6 “ ” for further information of financial instruments under the measurement alternative. |
| (7) |
Includes non-financial assets carried at fair value on a recurring basis. |
|
| Fair value, level 3 assets and liabilities measured on recurring basis, unrealized gains (losses) |
The following table presents the amounts of unrealized gains (losses) for the years ended March 31, 2025 and 2026, relating to those financial instruments which Nomura classified in Level 3 within the fair value hierarchy and that were still held by Nomura at the relevant consolidated balance sheet date.
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
| |
|
Unrealized gains / (losses) (1) |
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments |
|
|
|
|
|
|
|
|
|
|
¥ |
0 |
|
|
¥ |
(1 |
) |
Private equity and debt investments |
|
|
(1 |
) |
|
|
1 |
|
Foreign government, agency and municipal securities |
|
|
0 |
|
|
|
1 |
|
Bank and corporate debt securities and loans for trading purposes |
|
|
(6 |
) |
|
|
5 |
|
Commercial mortgage-backed securities (“CMBS”) |
|
|
7 |
|
|
|
0 |
|
Residential mortgage-backed securities (“RMBS”) |
|
|
2 |
|
|
|
(2 |
) |
Real estate-backed securities |
|
|
5 |
|
|
|
(3 |
) |
Collateralized debt obligations (“CDOs”) and other |
|
|
(24 |
) |
|
|
(5 |
) |
Investment trust funds and other |
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Total trading assets and private equity and debt investments |
|
|
(17 |
) |
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3 |
) |
|
|
19 |
|
|
|
|
(23 |
) |
|
|
(2 |
) |
|
|
|
(26 |
) |
|
|
(16 |
) |
Foreign exchange contracts |
|
|
(7 |
) |
|
|
(11 |
) |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
(57 |
) |
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
¥ |
(74 |
) |
|
¥ |
(16 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
14 |
|
|
|
22 |
|
Collateralized agreements |
|
|
0 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Non-Trading debt Securities |
|
|
0 |
|
|
|
1 |
|
|
|
|
20 |
|
|
|
49 |
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
(40 |
) |
|
¥ |
56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrealized gains / (losses) (1) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
0 |
|
|
¥ |
0 |
|
Bank and corporate debt securities |
|
|
0 |
|
|
|
0 |
|
Collateralized debt obligation (“CDOs”) and other |
|
|
1 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
Total trading liabilities |
|
¥ |
1 |
|
|
¥ |
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(7 |
) |
|
|
1 |
|
|
|
|
1 |
|
|
|
1 |
|
|
|
|
24 |
|
|
|
5 |
|
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
¥ |
18 |
|
|
¥ |
6 |
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes gains and losses reported within Net gain on trading, Gain on private equity and debt investments , and also within Gain(loss) on investments in equity securities, Revenue and Other, Interest and dividends and in the consolidated statements of income. |
| (2) |
Derivatives which contain multiple types of risk are classified based on the primary risk type of the instrument. |
| (3) |
Includes non-financial assets carried at fair value on a recurring basis. |
| (4) |
Includes unrealized gains and losses of ¥10 billion and ¥(1) billion for the years ended March 31, 2025 and 2026 recognized in Other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period. |
|
| Information on investments where net asset value per share is calculated |
The following tables present information on these investments where NAV per share is calculated or disclosed as of March 31, 2025 and 2026. Investments are presented by major category relevant to the nature of Nomura’s business and risks.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
(if currently eligible) (2) |
|
|
|
|
|
|
¥ |
11 |
|
|
¥ |
4 |
|
|
|
Daily-Monthly |
|
|
|
|
|
|
|
|
19 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
Private equity funds and private credit funds |
|
|
43 |
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
77 |
|
|
¥ |
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(if currently eligible) (2) |
|
|
|
|
|
|
¥ |
33 |
|
|
¥ |
2 |
|
|
|
Daily-Monthly |
|
|
|
|
|
|
|
|
20 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
Private equity funds and private credit funds |
|
|
63 |
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
0 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
119 |
|
|
¥ |
13 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
The contractual amount of any unfunded commitments Nomura is required to make to the entities in which the invest ment is held. |
| (2) |
The frequency with which Nomura is permitted to redeem investments. |
| (3) |
The range in prior notice period for redemption. |
|
| Gains (losses) due to changes in fair value for financial instruments measured at fair value using fair value option |
The following table presents gains (losses) due to changes in fair value for financial instruments carried at FV-NI using the FVO for the years ended March 31, 2024, 2025 and 2026.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Trading assets and private equity and debt investments (2) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
0 |
|
|
¥ |
4 |
|
|
¥ |
16 |
|
Private equity and debt investments |
|
|
2 |
|
|
|
2 |
|
|
|
1 |
|
|
|
|
54 |
|
|
|
45 |
|
|
|
52 |
|
Collateralized agreements (3) |
|
|
6 |
|
|
|
20 |
|
|
|
12 |
|
|
|
|
22 |
|
|
|
15 |
|
|
|
37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
84 |
|
|
¥ |
86 |
|
|
¥ |
118 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
13 |
|
|
¥ |
153 |
|
|
¥ |
83 |
|
|
|
|
8 |
|
|
|
6 |
|
|
|
38 |
|
Collateralized financing (3) |
|
|
(17 |
) |
|
|
(23 |
) |
|
|
(17 |
) |
Long-term borrowings (5)(6) |
|
|
(110 |
) |
|
|
(48 |
) |
|
|
12 |
|
|
|
|
(1 |
) |
|
|
(1 |
) |
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
(107 |
) |
|
¥ |
87 |
|
|
¥ |
105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes gains and losses reported primarily within Revenue – Net gain on trading and in the consolidated statements of income. |
| (2) |
Includes equity investments that would have been accounted for under the equity method had Nomura not chosen to elect the FVO. |
| (3) |
Includes reverse repurchase and repurchase agreements. |
| (4) |
Includes non-trading debt securities. |
| (5) |
Includes structured notes and other financial liabilities. |
| (6) |
Includes secured financing transactions arising from transfers of financial assets which did not meet the criteria for sales accounting. |
| (7) |
Includes unfunded written loan commitments. |
|
| Schedule of impact of changes in its own creditworthiness on certain financial liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Changes recognized as a credit (debit) to other comprehensive income |
|
¥ |
26 |
|
|
¥ |
(55 |
) |
Credit (debit) amounts reclassified to earnings |
|
|
0 |
|
|
|
(1 |
) |
Cumulative credit balance recognized in accumulated other comprehensive income |
|
|
78 |
|
|
|
22 |
|
|
| Geographic allocations of trading assets related to government, agency, municipal securities |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government, agency and municipal securities |
|
¥ |
2,896 |
|
|
¥ |
2,629 |
|
|
¥ |
2,655 |
|
|
¥ |
1,470 |
|
|
¥ |
9,650 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Government, agency and municipal securities |
|
¥ |
4,125 |
|
|
¥ |
3,141 |
|
|
¥ |
2,587 |
|
|
¥ |
1,416 |
|
|
¥ |
11,269 |
|
| (1) |
Other than above, there were ¥313 billion and ¥653 billion of government, agency and municipal securities reported within Non-trading debt securities in the consolidated balance sheets as of March 31, 2025 and 2026, respectively. These securities are primarily Japanese government, agency and municipal securities. |
|
| Carrying values, fair values and classification within the fair value hierarchy for certain classes of financial instrument |
The following tables present carrying values, fair values and classification within the fair value hierarchy for certain classes of financial instrument as of March 31, 2025 and 2026.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
¥ |
4,424 |
|
|
¥ |
4,424 |
|
|
¥ |
4,424 |
|
|
¥ |
— |
|
|
¥ |
— |
|
|
|
|
642 |
|
|
|
642 |
|
|
|
— |
|
|
|
642 |
|
|
|
— |
|
Deposits with stock exchanges and other segregated cash |
|
|
448 |
|
|
|
448 |
|
|
|
— |
|
|
|
448 |
|
|
|
— |
|
|
|
|
6,022 |
|
|
|
6,020 |
|
|
|
— |
|
|
|
3,436 |
|
|
|
2,584 |
|
Securities purchased under agreements to resell |
|
|
14,005 |
|
|
|
14,005 |
|
|
|
— |
|
|
|
13,991 |
|
|
|
14 |
|
|
|
|
4,659 |
|
|
|
4,659 |
|
|
|
— |
|
|
|
4,659 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
30,200 |
|
|
¥ |
30,198 |
|
|
¥ |
4,424 |
|
|
¥ |
23,176 |
|
|
¥ |
2,598 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
1,117 |
|
|
¥ |
1,117 |
|
|
¥ |
— |
|
|
¥ |
1,081 |
|
|
¥ |
36 |
|
Deposits received at banks |
|
|
3,106 |
|
|
|
3,106 |
|
|
|
— |
|
|
|
3,092 |
|
|
|
14 |
|
Securities sold under agreements to repurchase |
|
|
16,288 |
|
|
|
16,288 |
|
|
|
— |
|
|
|
16,288 |
|
|
|
— |
|
|
|
|
1,965 |
|
|
|
1,965 |
|
|
|
— |
|
|
|
1,965 |
|
|
|
— |
|
|
|
|
393 |
|
|
|
393 |
|
|
|
— |
|
|
|
393 |
|
|
|
— |
|
|
|
|
13,374 |
|
|
|
13,385 |
|
|
|
10 |
|
|
|
12,879 |
|
|
|
496 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
36,243 |
|
|
¥ |
36,254 |
|
|
¥ |
10 |
|
|
¥ |
35,698 |
|
|
¥ |
546 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
¥ |
4,299 |
|
|
¥ |
4,299 |
|
|
¥ |
4,299 |
|
|
¥ |
— |
|
|
¥ |
— |
|
|
|
|
710 |
|
|
|
710 |
|
|
|
— |
|
|
|
710 |
|
|
|
— |
|
Deposits with stock exchanges and other segregated cash |
|
|
641 |
|
|
|
641 |
|
|
|
— |
|
|
|
641 |
|
|
|
— |
|
|
|
|
7,742 |
|
|
|
7,740 |
|
|
|
— |
|
|
|
4,449 |
|
|
|
3,291 |
|
Securities purchased under agreements to resell |
|
|
13,210 |
|
|
|
13,210 |
|
|
|
— |
|
|
|
13,195 |
|
|
|
15 |
|
|
|
|
4,340 |
|
|
|
4,340 |
|
|
|
— |
|
|
|
4,340 |
|
|
|
— |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
30,942 |
|
|
¥ |
30,940 |
|
|
¥ |
4,299 |
|
|
¥ |
23,335 |
|
|
¥ |
3,306 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
1,753 |
|
|
¥ |
1,753 |
|
|
¥ |
— |
|
|
¥ |
1,710 |
|
|
¥ |
43 |
|
Deposits received at banks |
|
|
3,667 |
|
|
|
3,667 |
|
|
|
— |
|
|
|
3,655 |
|
|
|
12 |
|
Securities sold under agreements to repurchase |
|
|
15,234 |
|
|
|
15,234 |
|
|
|
— |
|
|
|
15,234 |
|
|
|
— |
|
|
|
|
2,448 |
|
|
|
2,448 |
|
|
|
— |
|
|
|
2,448 |
|
|
|
— |
|
|
|
|
384 |
|
|
|
384 |
|
|
|
— |
|
|
|
384 |
|
|
|
— |
|
|
|
|
15,545 |
|
|
|
15,562 |
|
|
|
11 |
|
|
|
15,085 |
|
|
|
466 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
39,031 |
|
|
¥ |
39,048 |
|
|
¥ |
11 |
|
|
¥ |
38,516 |
|
|
¥ |
521 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
Includes financial instruments which are carried at fair value on a recurring basis. |
| (2) |
Carrying values are shown after deducting relevant allowances for current expected credit losses. |
|
| Equity securities subject to contractual sale restrictions |
The following table presents a summary of equity securities primarily reported within in consolidated balance sheet which are subject to contractual sale restrictions as of March 31, 2025 and 2026.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
200,658 |
|
|
¥ |
9 |
|
|
¥ |
200,621 |
|
|
¥ |
28 |
|
Consent from third parties |
|
|
7,806 |
|
|
|
18 |
|
|
|
— |
|
|
|
7,788 |
|
|
|
|
2,148 |
|
|
|
— |
|
|
|
— |
|
|
|
2,148 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
210,612 |
|
|
¥ |
27 |
|
|
¥ |
200,621 |
|
|
¥ |
9,964 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
|
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
250,291 |
|
|
¥ |
250,291 |
|
|
¥ |
— |
|
|
¥ |
— |
|
Consent from third parties |
|
|
8,054 |
|
|
|
— |
|
|
|
— |
|
|
|
8,054 |
|
|
|
|
3,745 |
|
|
|
— |
|
|
|
— |
|
|
|
3,745 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
¥ |
262,090 |
|
|
¥ |
250,291 |
|
|
¥ |
— |
|
|
¥ |
11,799 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| (1) |
No specific conditions could cause a lapse in the sale restrictions as disclosed above. |
|